Trial Profile
A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2020
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary) ; Goserelin
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms EDVART
- 19 Jul 2019 As per European Clinical Trials Database record trial is completed in UK (End Date: 5 Sep 2013).
- 18 Feb 2017 Final results assessing effect of decapeptyl compared with zoladex preradiotherapy on quality of life, presented at the 2017 Genitourinary Cancers Symposium
- 17 Jun 2013 Accrual to date is 110% according to United Kingdom Clinical Research Network.